<unk>  is a combination product made up of three medications: *<unk> , an inhaled corticosteroid (ICS) * umeclidinium, a long-acting muscarinic antagonist (LAMA) (i.e. an anticholinergic medication) *<unk> , a long-acting beta-agonist (LABA) (specifically, a beta2-adrenergic receptor agonist) In the setting of chronic obstructive pulmonary disease (COPD), an inhaled corticosteroid (ICS) will reduce inflammation while a long-acting muscarinic antagonist (LAMA) and a long-acting beta-agonist (LABA) will cause bronchodilation (widening and opening of the bronchi, the airways of the lungs). Because LABAs and LAMAs are "long-acting", they are not used for acute problems with breathing.
Fluticasone furoate/umeclidinium bromide/vilanterol
Beclometasone/formoterol/glycopyrronium bromide
Budesonide/glycopyrronium bromide/formoterol
Budesonide/formoterol
Aclidinium bromide/formoterol
Umeclidinium bromide/vilanterol
Glycopyrronium bromide/formoterol
Olopatadine/mometasone